The Saudi Arabia Capital Markets Authority has approved Dallah Healthcare Company's request to raise its capital to SAR 1,218,897,230 from SAR 1,015,747,690 by issuing one bonus share for every five existing shares. The increase will raise the company's outstanding shares to 121,889,723 from 101,574,769, adding 20,314,954 shares. The capitalization will be funded by transferring SAR 109,534,568 from the share premium account and SAR 93,614,972 from the statutory reserve to capital. The bonus share entitlement will apply to shareholders registered at the Security Depository Center at the close of the second trading day after the due date, which the company's board will determine later. The extraordinary general assembly must be held within six months of the approval, and the company must meet all regulatory requirements and applicable laws.
Saudi Arabia Capital Markets Authority2026-07-05
Saudi Arabia Capital Markets Authority approves Dallah Healthcare capital increase to SAR 1.22 billion through one for five bonus share issue
The Saudi Arabia Capital Markets Authority approved Dallah Healthcare's capital increase to SAR 1,218,897,230 from SAR 1,015,747,690 through a one for five bonus share issue. The transaction will be funded from the company's share premium and statutory reserve accounts and will add 20,314,954 shares. The extraordinary general assembly must be held within six months.